CARCINOMA, HEPATOCELLULAR
Clinical trials for CARCINOMA, HEPATOCELLULAR explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, HEPATOCELLULAR trials appear
Sign up with your email to follow new studies for CARCINOMA, HEPATOCELLULAR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Triple-Drug attack on liver cancer shows promise in early trial
Disease control Recruiting nowThis study tests a new three-drug combination (irpagratinib, atezolizumab, and bevacizumab) in people with advanced liver cancer that cannot be removed by surgery. The goal is to see if the combination is safe and can shrink or control tumors. About 33 adults with a specific gene…
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: PHASE2 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated May 26, 2026 05:10 UTC
-
New drug combo aims to stop liver cancer from spreading
Disease control Recruiting nowThis study tests whether adding the drug tislelizumab after standard local treatments (like radiation) can help control advanced liver cancer that cannot be removed by surgery. The goal is to prevent the cancer from growing or spreading. About 35 adults with liver cancer will tak…
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: PHASE2 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated May 26, 2026 05:01 UTC
-
New hope for liver cancer: pfizer launches trial of PF-08634404
Disease control Recruiting nowThis study tests a new medicine, PF-08634404, given alone or with another drug (ipilimumab) for adults with advanced liver cancer that cannot be removed by surgery. The goal is to see if the treatment is safe and shrinks tumors. About 138 participants will receive the drug throug…
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: PHASE1, PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated May 26, 2026 04:36 UTC
-
New hope for Hard-to-Treat cancers: first human trial of AST-201 begins
Disease control Recruiting nowThis study tests a new drug called AST-201 in people with advanced solid tumors that have a protein called GPC3. The main goal is to check the drug's safety and find the right dose. About 70 adults with liver or lung cancer that has not responded to other treatments will take par…
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: PHASE1 • Sponsor: Aptamer Sciences, Inc. • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New combo attack shrinks untreatable liver tumors?
Disease control Recruiting nowThis study tests a powerful mix of treatments for people with advanced liver cancer that cannot be surgically removed. The approach combines tumor destruction (ablation), targeted therapy (lenvatinib), immunotherapy (tislelizumab), and a procedure that blocks the tumor's blood su…
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: NA • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
Can a better scan save lives from liver cancer? major trial launches
Prevention Recruiting nowThis study tests whether a special MRI scan can find liver cancer earlier than the standard ultrasound in people with cirrhosis. Earlier detection could lead to more effective treatments and lower the chance of dying from liver cancer. The trial will involve 4,700 participants an…
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Prevention
Last updated May 20, 2026 11:55 UTC
-
New trial aims to catch liver cancer earlier in thousands at risk
Prevention Recruiting nowThis study tests whether a blood test (GALAD) is better than ultrasound for finding liver cancer early in 5500 people with cirrhosis or chronic hepatitis B. Participants will be randomly assigned to one of two screening methods every six months. The goal is to see which approach …
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: PHASE4 • Sponsor: University of Texas Southwestern Medical Center • Aim: Prevention
Last updated May 14, 2026 12:02 UTC
-
New study aims to uncover how liver cancer affects older patients
Knowledge-focused Recruiting nowThis study looks at how advanced liver cancer behaves and is treated in people aged 65 and older. Researchers will track 84 participants over time, using special assessments to measure aging and side effects. The goal is to learn more about the disease and improve care for older …
Matched conditions: CARCINOMA, HEPATOCELLULAR
Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC